Rhythm Pharmaceuticals, Inc. logo

Rhythm Pharmaceuticals, Inc.

NASDAQ:RYTM

Overview | Financials
Company Name Rhythm Pharmaceuticals, Inc.
Symbol RYTM
Currency USD
Price 53.66
Market Cap 3,297,787,986
Dividend Yield 0%
52-week-range 35.17 - 68.58
Industry Biotechnology
Sector Healthcare
CEO Dr. David P. Meeker M.D.
Website https://www.rhythmtx.com

An error occurred while fetching data.

About Rhythm Pharmaceuticals, Inc.

Rhythm Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of therapeutics for the treatment of rare genetic diseases of obesity. The company's lead product candidate is IMCIVREE, a potent melanocortin-4 receptor for the treatment of pro-opiomelanocortin (POMC), proprotein convertase subtilisin/kexin type 1, leptin receptor (LEPR) deficiency

Related Stocks

Beyond Air, Inc. logo

Beyond Air, Inc.

XAIR

0.359 USD

Fusion Pharmaceuticals Inc. logo

Fusion Pharmaceuticals Inc.

FUSN

21.55 USD

Profound Medical Corp. logo

Profound Medical Corp.

PROF

7.38 USD

Talkspace, Inc. logo

Talkspace, Inc.

TALK

2.94 USD

Aldeyra Therapeutics, Inc. logo

Aldeyra Therapeutics, Inc.

ALDX

5.025 USD

Mainz Biomed B.V. logo

Mainz Biomed B.V.

MYNZ

5 USD

CymaBay Therapeutics, Inc. logo

CymaBay Therapeutics, Inc.

CBAY

32.48 USD

Financials

Numbers are in millions USD

Numbers are in millions USD